Sarjana Raikwar
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Nanocomposite Films for Food Packaging
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 9
-
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 3
- Co-authors
- Tejal Mehta (2 shared papers)Atul Garkal (2 shared papers)Nikhar Vishwakarma (2 shared papers)Satish Rojekar (2 shared papers)Harshad S. Kapare (2 shared papers)Amol D. Gholap (2 shared papers)Uday S. Annapure (1 shared paper)Harsh B. Jadhav (1 shared paper)
- Journals
- AAPS PharmSciTech (4 papers)Current Drug Targets (2 papers)Current Drug Delivery (1 paper)Carbohydrate Polymers (1 paper)Journal of Drug Delivery Science and Technology (1 paper)
- Partner nations
- IndiaUnited States
In The Last Decade
Sarjana Raikwar
17 papers receiving 254 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 96
- Pharmaceutical Science 31
- Molecular Medicine 17
- Rehabilitation 13
- Geriatrics and Gerontology 6
Countries citing papers authored by Sarjana Raikwar
This map shows the geographic impact of Sarjana Raikwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarjana Raikwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarjana Raikwar more than expected).
Fields of papers citing papers by Sarjana Raikwar
This network shows the impact of papers produced by Sarjana Raikwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarjana Raikwar. The network helps show where Sarjana Raikwar may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarjana Raikwar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 102 | |
| 2 | 2024 | 37 | |
| 3 | 2024 | 26 | |
| 4 | 2022 | 17 | |
| 5 | 2019 | 14 | |
| 6 | 2024 | 14 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2018 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2025 | 4 | |
| 13 | 2025 | 3 | |
| 14 | 2024 | 2 | |
| 15 | Nanocarrier(s) as an Emerging Platform for Breast Cancer Therapy | 2019 | 1 |
| 16 | 2024 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Sarjana Raikwar
Sarjana Raikwar is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Oncology and Pharmaceutical Science, having authored 21 papers that have together received 262 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (4 papers), Dendrimers and Hyperbranched Polymers (3 papers), Advanced Drug Delivery Systems (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Nanoplatforms for cancer theranostics (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Graphene and Nanomaterials Applications (2 papers). The work is most often cited by research in Biomaterials (96 citations), Pharmaceutical Science (31 citations), Molecular Medicine (17 citations), Rehabilitation (13 citations) and Geriatrics and Gerontology (6 citations). Sarjana Raikwar has collaborated with scholars based in India and United States. Frequent co-authors include Tejal Mehta, Atul Garkal, Nikhar Vishwakarma, Satish Rojekar, Harshad S. Kapare, Amol D. Gholap, Uday S. Annapure, Harsh B. Jadhav, Preeti Patel and Balak Das Kurmi. Their work appears in journals such as AAPS PharmSciTech, Current Drug Targets, Current Drug Delivery, Carbohydrate Polymers and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.